Daniel L. Shawler

Human immune response to multiple injections of murine monoclonal IgG.

Daniel L. Shawler, Richard M. Bartholomew, Leia M. Smith et al. · The Journal of Immunology · 1985 · 426 citations · Full text

Phase II Study of Belagenpumatucel-L, a Transforming Growth Factor Beta-2 Antisense Gene-Modified Allogeneic Tumor Cell Vaccine in Non–Small-Cell Lung Cancer

John Nemunaitis, Robert O. Dillman, Paul Schwarzenberger et al. · Journal of Clinical Oncology · 2006 · 358 citations · Full text

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.

Habib Fakhrai, Oliver Dorigo, Daniel L. Shawler et al. · Proceedings of the National Academy of Sciences · 1996 · 338 citations · Full text

A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer

Giuseppe Giaccone, Lyudmila Bazhenova, John Nemunaitis et al. · European Journal of Cancer · 2015 · 266 citations

Vaccination, Tumor Immunology, Medicine +10

Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.

Robert O. Dillman, Daniel L. Shawler, Jacquelyn B. Dillman et al. · Journal of Clinical Oncology · 1984 · 175 citations

Chronic Lymphocytic Leukemia, Immunology, Pathology +16